Nonapeptide-1 CAS: 158563-45-2

CAS NO: 158563-45-2
Nonapeptide-1
Chemical Name: Nonapeptide-1
Molecular Formula: C61H87N15O9S
Formula Weight: 1206.5
CAS No.: 158563-45-2
Description Review
Description

Nonapeptide-1 is a skincare ingredient used in various cosmetic formulations to even out skin tone and reduce the appearance of hyperpigmentation. In this article, we will explore the properties, uses, potential benefits, and side effects of this product.

Chemical Properties The chemical name of Nonapeptide-1 is Acetyl-L-Tyrosyl-L-Arginyl-L-Serine (Ac-Tyr-Arg-Ser), and its molecular formula is C21H36N8O7. The compound has a formula weight of 528.56 g/mol and a CAS number of 158563-45-2.

Top Ten Keywords and Synonyms

  1. Skin Lightening
  2. Cosmetics
  3. Anti-Aging
  4. Brightening
  5. Skin Tone Correction
  6. Melanin Inhibitor
  7. Dermatology
  8. Pigment Reduction
  9. Radiance Enhancement
  10. Tyrosinase Inhibition

Health Benefits of Nonapeptide-1 Nonapeptide-1 has been shown to have potential health benefits, including skin lightening, anti-aging effects, brightening, skin tone correction, melanin inhibition, pigment reduction, radiance enhancement, and tyrosinase inhibition.

Potential Effects Nonapeptide-1 works by inhibiting the activity of the enzyme tyrosinase, which is responsible for the production of melanin. By reducing melanin synthesis, Nonapeptide-1 may help even out skin tone and reduce the appearance of hyperpigmentation. Additionally, the compound may have potential anti-aging effects and enhance overall radiance by improving skin texture and minimizing fine lines.

Product Mechanism Nonapeptide-1 works by inhibiting the activity of the enzyme tyrosinase, which is responsible for the production of melanin. By preventing melanin synthesis, Nonapeptide-1 may reduce the appearance of hyperpigmentation and even out skin tone. Additionally, the compound may have antioxidant properties, potentially protecting against oxidative stress-induced skin damage.

Safety Nonapeptide-1 is considered safe for use in skincare products but should be handled with care and stored properly. Ingestion or inhalation of the product may cause irritation, respiratory distress, or other adverse effects. Proper protective measures should be taken when handling Nonapeptide-1.

Side Effects Few studies have explored the potential side effects of Nonapeptide-1, but it is generally considered safe for use in various cosmetic formulations. However, people with allergies to the compound should avoid using products containing it.

Dosing Information The appropriate dosing information for Nonapeptide-1 varies depending on the intended use of the compound. In cosmetic formulations, dosages are typically limited to small amounts and formulated according to industry guidelines.

Conclusion In conclusion, Nonapeptide-1 is a promising compound with potential benefits in various cosmetic formulations, including skin lightening, anti-aging effects, brightening, skin tone correction, melanin inhibition, pigment reduction, radiance enhancement, and tyrosinase inhibition. The compound works by inhibiting the activity of the enzyme tyrosinase, leading to potential lightening effects on the skin. While the compound is generally considered safe for use, proper precautions should be taken when handling it to avoid adverse effects. With further research, scientists may uncover additional potential benefits of Nonapeptide-1, making it an even more valuable resource in the cosmetics industry. However, it is important to note that the compound should only be used in accordance with industry guidelines and under the supervision of qualified professionals

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us